Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain
The phenotype of an attenuated live vaccine depends on gene mutation achieved by, for example, many passages in cultured cells. Viral clones with preferable phenotypes are selected and the causative genetic mutation(s) are later identified. LC16m8 is an example of a highly attenuated smallpox vaccin...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c076bebff9cb4efaaa2aa2fcdc9bf4c2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c076bebff9cb4efaaa2aa2fcdc9bf4c2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c076bebff9cb4efaaa2aa2fcdc9bf4c22021-11-25T16:47:33ZEffect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain10.3390/biology101111582079-7737https://doaj.org/article/c076bebff9cb4efaaa2aa2fcdc9bf4c22021-11-01T00:00:00Zhttps://www.mdpi.com/2079-7737/10/11/1158https://doaj.org/toc/2079-7737The phenotype of an attenuated live vaccine depends on gene mutation achieved by, for example, many passages in cultured cells. Viral clones with preferable phenotypes are selected and the causative genetic mutation(s) are later identified. LC16m8 is an example of a highly attenuated smallpox vaccine that was developed and licensed in Japan in the 1970s. LC16m8 was obtained by the passaging of Lister strain, with indicators of small plaque formation and temperature sensitivity as virus phenotypes. This strain can replicate in mammalian cells and provides robust cellular and humoral immunity, as well as long-term immune memory. Recent studies using proteome-wide antigen arrays have revealed that antibody production against LC16m8 and other VACVs differs largely among individuals. Moreover, associations between SNPs in immune-related genes and immune outcomes have been increasingly found. These results lead to predicting adverse events of a vaccine, which is a purpose of vaccinomics. Studies on VACV will continue to contribute to the understanding of host-pathogen interactions and to development of a vaccine for other infectious and non-infectious diseases. Here, we review studies of VACV, including our recent research on LC16m8, with a focus on the phenotype and genotype, and we discuss future research directions.Akiko EtoNorio YamamotoYasuhiro KanataniMDPI AGarticlevaccinia virusvaccineLC16m8immune responsehumoral immunityinterindividual differenceBiology (General)QH301-705.5ENBiology, Vol 10, Iss 1158, p 1158 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
vaccinia virus vaccine LC16m8 immune response humoral immunity interindividual difference Biology (General) QH301-705.5 |
spellingShingle |
vaccinia virus vaccine LC16m8 immune response humoral immunity interindividual difference Biology (General) QH301-705.5 Akiko Eto Norio Yamamoto Yasuhiro Kanatani Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain |
description |
The phenotype of an attenuated live vaccine depends on gene mutation achieved by, for example, many passages in cultured cells. Viral clones with preferable phenotypes are selected and the causative genetic mutation(s) are later identified. LC16m8 is an example of a highly attenuated smallpox vaccine that was developed and licensed in Japan in the 1970s. LC16m8 was obtained by the passaging of Lister strain, with indicators of small plaque formation and temperature sensitivity as virus phenotypes. This strain can replicate in mammalian cells and provides robust cellular and humoral immunity, as well as long-term immune memory. Recent studies using proteome-wide antigen arrays have revealed that antibody production against LC16m8 and other VACVs differs largely among individuals. Moreover, associations between SNPs in immune-related genes and immune outcomes have been increasingly found. These results lead to predicting adverse events of a vaccine, which is a purpose of vaccinomics. Studies on VACV will continue to contribute to the understanding of host-pathogen interactions and to development of a vaccine for other infectious and non-infectious diseases. Here, we review studies of VACV, including our recent research on LC16m8, with a focus on the phenotype and genotype, and we discuss future research directions. |
format |
article |
author |
Akiko Eto Norio Yamamoto Yasuhiro Kanatani |
author_facet |
Akiko Eto Norio Yamamoto Yasuhiro Kanatani |
author_sort |
Akiko Eto |
title |
Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain |
title_short |
Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain |
title_full |
Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain |
title_fullStr |
Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain |
title_full_unstemmed |
Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain |
title_sort |
effect of serial passage on the pathogenicity and immunogenicity of vaccinia virus lc16m8 strain |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/c076bebff9cb4efaaa2aa2fcdc9bf4c2 |
work_keys_str_mv |
AT akikoeto effectofserialpassageonthepathogenicityandimmunogenicityofvacciniaviruslc16m8strain AT norioyamamoto effectofserialpassageonthepathogenicityandimmunogenicityofvacciniaviruslc16m8strain AT yasuhirokanatani effectofserialpassageonthepathogenicityandimmunogenicityofvacciniaviruslc16m8strain |
_version_ |
1718412980617478144 |